Full Description
Cardiovascular and metabolic diseases remain the number one cause of death in developed countries and their prevalence is increasing rapidly in developing nations. This book brings together the recent information on these disorders and the links that exist between them in order to provide a complete picture of drug discovery for these conditions.
The main three sections comprehensively discuss obesity, hypertension and cardiovascular disease, and diabetes in turn, following an introduction to the molecular links between them. The final chapter provides perspectives on future directions of the field. Chapters are contributed by leaders in the field from academia and industry and cover biomarkers, risk factors, gene-environment interactions, therapies and the various types of animal models that have been used to study each disease. Case studies describing the implementation of animal models in drug development further enhance the book's usefulness as a comprehensive guide to this important therapeutic area.
Providing a full picture of the various types of animal models that have been used to study obesity, hypertension, and insulin resistance with recent case studies, this book provides a valuable resource for medicinal chemists and clinicians working in these disease areas.
Contents
The Relevance of Biomarkers, Risk Factors and Gene-environment;
Molecular Links between Obesity, Hypertension and Metabolic Dysfunction;
Discovery of Biomarkers of Obesity;
Risk Factors for Obesity;
Gene-environment Interactions in Obesity;
New Drug Design and Therapeutic Development for Weight Reduction: Preclinical Studies and Clinical Trials;
Discovery of Biomarkers of Hypertension and Cardiovascular Disease;
Risk Factors for Hypertension and Cardiovascular Disease;
Gene-environment Interaction and Oxidative Stress in Cardiovascular Disease;
New Drug Design and Therapeutic Development for Hypertension and Cardiovascular Disease;
Discovery of Biomarkers of Diabetes Type 1 and Type 2;
Risk Factors for Diabetes Type 1 and Type 2;
Gene-environment Interactions in Diabetes Type 1 and Type 2;
New Drug Design and Therapeutic Development for Diabetes Type 1 and Type 2;
New Insights and Future Directions
